Company intelligence / Profile preview

Topo Therapeutics

Cambridge, Massachusetts, United Statestopo-tx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

No detailed public clinical trial results are available yet. The company is poised to rapidly advance its transporter and ion channel programs leveraging recent scientific advances. Leadership has prior experience advancing multiple programs into clinic with pharma partners.

Therapeutic areas: Neurology
Modalities: Small molecule therapeutics targeting transmembrane proteins including transporters and ion channels[1][2][3][4].
Industry: Biotech

Beyond the preview

Go deeper on Topo Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Topo Therapeutics.

Explore the full profile